Rhinovirus Withdrawn Phase 2 Trials for BTA798 (DB05181)

IndicationStatusPhase
DBCOND0035950 (Rhinovirus)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03024177A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus InfectionTreatment